Brokerages Expect ProAssurance Co. (PRA) Will Announce Quarterly Sales of $214.65 Million
Analysts predict that ProAssurance Co. (NYSE:PRA) will announce $214.65 million in sales for the current quarter, according to Zacks. Three analysts have provided estimates for ProAssurance’s earnings. The lowest sales estimate is $213.32 million and the highest is $215.32 million. ProAssurance reported sales of $220.27 million during the same quarter last year, which would suggest a negative year-over-year growth rate of 2.6%. The firm is scheduled to report its next quarterly earnings results after the market closes on Wednesday, February 21st.
According to Zacks, analysts expect that ProAssurance will report full year sales of $214.65 million for the current year, with estimates ranging from $843.06 million to $845.05 million. For the next year, analysts forecast that the company will post sales of $872.11 million per share, with estimates ranging from $857.68 million to $880.96 million. Zacks’ sales calculations are an average based on a survey of research analysts that follow ProAssurance.
Several research analysts recently issued reports on PRA shares. Zacks Investment Research raised shares of ProAssurance from a “hold” rating to a “buy” rating and set a $68.00 target price on the stock in a research note on Wednesday, December 13th. Keefe, Bruyette & Woods reissued a “hold” rating and set a $61.00 target price on shares of ProAssurance in a research note on Wednesday, December 6th. Finally, Boenning Scattergood reissued a “hold” rating on shares of ProAssurance in a research note on Tuesday, November 7th. One equities research analyst has rated the stock with a sell rating and four have assigned a hold rating to the company. ProAssurance currently has an average rating of “Hold” and an average price target of $59.33.
Institutional investors have recently added to or reduced their stakes in the business. Flinton Capital Management LLC lifted its stake in shares of ProAssurance by 55.3% in the second quarter. Flinton Capital Management LLC now owns 2,560 shares of the insurance provider’s stock valued at $156,000 after buying an additional 912 shares in the last quarter. Zurcher Kantonalbank Zurich Cantonalbank lifted its stake in shares of ProAssurance by 50.4% in the fourth quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 3,109 shares of the insurance provider’s stock valued at $178,000 after buying an additional 1,042 shares in the last quarter. Verition Fund Management LLC bought a new position in shares of ProAssurance in the second quarter valued at $211,000. Everence Capital Management Inc. bought a new position in shares of ProAssurance in the fourth quarter valued at $202,000. Finally, HighTower Advisors LLC bought a new position in shares of ProAssurance in the second quarter valued at $226,000. 79.89% of the stock is currently owned by hedge funds and other institutional investors.
Shares of ProAssurance (PRA) traded up $0.20 during midday trading on Friday, reaching $51.70. 94,272 shares of the company traded hands, compared to its average volume of 234,316. The company has a market capitalization of $2,745.54, a price-to-earnings ratio of 22.35 and a beta of 0.47. ProAssurance has a fifty-two week low of $50.35 and a fifty-two week high of $63.45. The company has a debt-to-equity ratio of 0.22, a quick ratio of 0.40 and a current ratio of 0.40.
TRADEMARK VIOLATION NOTICE: This piece was reported by The Cerbat Gem and is the property of of The Cerbat Gem. If you are reading this piece on another site, it was illegally copied and republished in violation of United States & international trademark and copyright legislation. The original version of this piece can be viewed at https://www.thecerbatgem.com/2018/02/13/brokerages-expect-proassurance-co-pra-will-announce-quarterly-sales-of-214-65-million.html.
ProAssurance Company Profile
ProAssurance Corporation (ProAssurance) is a holding company for property and casualty insurance companies. The Company provides professional liability insurance for healthcare professionals and facilities, professional liability insurance for attorneys, liability insurance for medical technology and life sciences risks, and workers’ compensation insurance.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for ProAssurance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ProAssurance and related companies with MarketBeat.com's FREE daily email newsletter.